Argenx
ARGX
#427
Rank
โ‚ฌ46.57 B
Marketcap
747,92ย โ‚ฌ
Share price
-1.30%
Change (1 day)
24.25%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚ฌ46.57 Billion

As of December 2025 Argenx has a market cap of โ‚ฌ46.57 Billion. This makes Argenx the world's 427th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ46.57 B29.42%
2024โ‚ฌ35.98 B76.3%
2023โ‚ฌ20.41 B4.48%
2022โ‚ฌ19.53 B20.32%
2021โ‚ฌ16.23 B42.44%
2020โ‚ฌ11.39 B85.66%
2019โ‚ฌ6.14 B100.34%
2018โ‚ฌ3.06 B83.42%
2017โ‚ฌ1.67 B
2014โ‚ฌ0.11 B

End of Day market cap according to different sources

On Dec 14th, 2025 the market cap of Argenx was reported to be:

โ‚ฌ45.61 Billion
by Nasdaq info icon info icon
โ‚ฌ46.57 Billion
by CompaniesMarketCap info icon info icon